Pathways in cancer, calcium signaling and transforming growth factor-β (TGF-β) signaling were significantly enriched (Fig. 1a–c), so were ECM receptor interaction, adheren junction and cell adhesion molecules (CAMs) signalings (Fig. 1d–f). The gene discussed is TGFB1; the disease is cancer.